Pneumonia, Viral clinical trials
The registry lists 156 studies for Pneumonia, Viral across more than 10 countries. 13 are recruiting or about to start. 34 of them are mainly about Pneumonia, Viral (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21. Counting its 2 narrower conditions too, such as COVID-19: 8,448 studies, 622 open.
Get an email when these change. Save the Pneumonia, Viral studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Pfizer (4) · Catholic University of the Sacred Heart (3) · Beyond Air Inc. (3) · Alexion Pharmaceuticals, Inc. (2) · Ain Shams University (2) · ZhiYong Peng (2) · Hospices Civils de Lyon (2) · University Hospital, Montpellier (2)
What is being tested here
Drugs under test in Pneumonia, Viral studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Ibuzatrelvir | 2 | 2 | 2 |
| BNT162 Vaccine | 2 | 1 | 2 |
| Acyclovir | 1 | 1 | 2 |
| Remdesivir | 1 | 1 | 1 |
| Hydroxychloroquine | 0 | 5 | 6 |
| Azithromycin | 0 | 3 | 4 |
| Tocilizumab | 0 | 1 | 4 |
| Cyproheptadine | 0 | 1 | 3 |
| Dexamethasone | 0 | 3 | 3 |
| Heparin | 0 | 1 | 2 |
Drug classes tested here Corticosteroids 6
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 6, phase 3 first
- Apr 2027A Study of COVID-19 Vaccine(s) in Children and Adults · Phase 3 · BioNTech SE
- Sep 2027A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
- Oct 2027A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
- Dec 2026Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) · All Natural Medicine Clinic, LLC
- Jul 2027Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors · Universitaire Ziekenhuizen KU Leuven
- Aug 2027A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age · BioNTech SE
Who these studies take
Of the 9 Pneumonia, Viral studies recruiting now, 8 (89%) set no upper age limit and 1 (11%) stop at 75 or younger. 3 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (22%) | 2 (22%) |
| 18 | 9 (100%) | 9 (100%) |
| 30 | 9 (100%) | 9 (100%) |
| 40 | 9 (100%) | 9 (100%) |
| 50 | 9 (100%) | 9 (100%) |
| 65 | 8 (89%) | 8 (89%) |
| 75 | 8 (89%) | 8 (89%) |
| 85 | 8 (89%) | 8 (89%) |
Across all 156 studies, recruiting or not: 13% stop at 75 or younger and 8% at 65; 19% take children; 1% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Pneumonia, Viral studies take
Of 30 observational studies under Pneumonia, Viral, half reached primary completion within 14 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 13 mo3–15 · 16 studies | — | — |
| Observational | 14 mo4–20 · 30 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 50 of 156. Browse all 156 → or search them.
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruitingNCT06679140Phase 319 countries
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruitingNCT07013474Phase 318 countries
- A Study of COVID-19 Vaccine(s) in Children and AdultsRecruitingNCT07798648Phase 31 country
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of AgeRecruitingNCT07730450Phase 41 country
- Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BALRecruitingNCT06134492Phase 31 country
- Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -Not yet recruitingNCT073869121 country
- Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress SyndromeRecruitingNCT067208181 country
- CardioVascular Disease Progression and Prognosis in COVID-19RecruitingNCT046067321 country
- Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)RecruitingNCT04790240Phase 1/21 country
- AI-based System for Assessing Suspected Viral Pneumonia Related Lung ChangesRecruitingNCT065015991 country
- "Efesovir" (FS-1) for COVID-19, Phase 2Not yet recruitingNCT05060705Phase 21 country
- Diagnostic Accuracy of Pocket-size Lung Ultrasound in Pneumonia Etiology and Complications in Hospitalized ChildrenNot yet recruitingNCT06296693Not applicable
- Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort StudyNot yet recruitingNCT056128931 country
- Nitric Oxide Therapy for COVID-19 Patients With Oxygen RequirementCompletedNCT04476992Phase 1/21 country
- Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.Active, not recruitingNCT05123755Phase 21 country
- Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19CompletedNCT043417661 country
- Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral InfectionTerminatedNCT06999603Phase 22 countries
- RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed AdultsActive, not recruitingNCT07816471
- A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of IbuzatrelvirCompletedNCT07552779Phase 11 country
- Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19TerminatedNCT04365101Phase 1/21 country
- Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among InpatientsCompletedNCT05976581Not applicable1 country
- Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19TerminatedNCT04305457Phase 21 country
- Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk FactorsActive, not recruitingNCT072381141 country
- French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management StudyCompletedNCT043404661 country
- Characterization of Persistent Pulmonary Abnormalities Following COVID-19 PneumoniaCompletedNCT04422613Not applicable1 country
- Stellate Ganglion Block for COVID-induced ParosmiaCompletedNCT06253806Phase 21 country
- Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU StudyCompletedNCT012718421 country
- Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 PneumoniaTerminatedNCT05531149Phase 314 countries
- Multiplex PCR for Severe Respiratory Infections During the COVID-19 PandemicCompletedNCT063497071 country
- A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)CompletedNCT04830800Phase 11 country
- Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 PneumoniaCompletedNCT05290441Not applicable1 country
- Cromolyn Sodium for Treatment of COVID-19 PneumoniaTerminatedNCT05077917Phase 31 country
- Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDSCompletedNCT04429555Phase 21 country
- Mesenchymal Stromal Cells for COVID-19 and Viral PneumoniasWithdrawnNCT05286255Phase 11 country
- Pediatric Helmet CPAP Pilot StudyTerminatedNCT04764929Not applicable1 country
- Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.CompletedNCT04878055Phase 32 countries
- Tobacco Use and the Risk of COVID-19 and Adverse OutcomesCompletedNCT053214331 country
- A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)TerminatedNCT04455815Phase 21 country
- Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and DeathCompletedNCT04914832Phase 41 country
- Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 SubjectsCompletedNCT04629703Phase 34 countries
- Antiviral Drugs on the Treatment of SARS-CoV-2CompletedNCT047277751 country
- Characteristics of Patients With COVID-19 in Meta State, ColombiaWithdrawnNCT04456426
- Rapid Empiric Treatment With Oseltamivir Study (RETOS)CompletedNCT01248715Phase 41 country
- Study Evaluating Diltiazem in Combination With Standard Treatment in the Management of Patients Hospitalized With COVID-19 PneumoniaWithdrawnNCT05563168Phase 21 country
- Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19)Status unknownNCT049482421 country
- Rehabilitation Treatment of Patients With COVID-19CompletedNCT05808361Not applicable1 country
- Diaphragmatic Echography in COVID-19 PneumoniaCompletedNCT058055791 country
- PTH - Preemptive Treatment for HerpesviridaeCompletedNCT02152358Phase 41 country
- Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated DeliriumWithdrawnNCT04513314Phase 4
- DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 PneumoniaStatus unknownNCT04836780Phase 31 country